Report Detail
Global Transdermal Drug Delivery System Market Insights, Forecast to 2025
- RnM2848241 |
- 31 January, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Other
The global Transdermal Drug Delivery System market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transdermal Drug Delivery System market based on company, product type, end user and key regions.
This report studies the global market size of Transdermal Drug Delivery System in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transdermal Drug Delivery System in these regions.
This research report categorizes the global Transdermal Drug Delivery System market by top players/brands, region, type and end user. This report also studies the global Transdermal Drug Delivery System market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis AG
Johnson & Johnson
Mylan Pharmaceuticals, Inc
Boehringer Ingelheim GmbH
Biogel Technology, Inc.
Transdermal Technologies, Inc.
Skyepharma PLC
Watson Pharmaceuticals, Inc
3M Company
Noven Pharmaceuticals, Inc
4P Therapeutics, LLC
Echo Therapeutics, Inc
Transdermal Corp
Market size by Product
Electroporation
Radiofrequency
Iontophoresis
Microporation
Other
Market size by End User
Central Nervous System (CNS)
Pain Management
Cardiovascular
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Transdermal Drug Delivery System market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Transdermal Drug Delivery System market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Transdermal Drug Delivery System companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Transdermal Drug Delivery System submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Transdermal Drug Delivery System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transdermal Drug Delivery System market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Transdermal Drug Delivery System Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Product
- 1.4.2 Electroporation
- 1.4.3 Radiofrequency
- 1.4.4 Iontophoresis
- 1.4.5 Microporation
- 1.4.6 Other
- 1.5 Market by End User
- 1.5.1 Global Transdermal Drug Delivery System Market Size Growth Rate by End User
- 1.5.2 Central Nervous System (CNS)
- 1.5.3 Pain Management
- 1.5.4 Cardiovascular
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Transdermal Drug Delivery System Market Size
- 2.1.1 Global Transdermal Drug Delivery System Revenue 2014-2025
- 2.1.2 Global Transdermal Drug Delivery System Sales 2014-2025
- 2.2 Transdermal Drug Delivery System Growth Rate by Regions
- 2.2.1 Global Transdermal Drug Delivery System Sales by Regions
- 2.2.2 Global Transdermal Drug Delivery System Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Transdermal Drug Delivery System Sales by Manufacturers
- 3.1.1 Transdermal Drug Delivery System Sales by Manufacturers
- 3.1.2 Transdermal Drug Delivery System Sales Market Share by Manufacturers
- 3.1.3 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
- 3.2 Transdermal Drug Delivery System Revenue by Manufacturers
- 3.2.1 Transdermal Drug Delivery System Revenue by Manufacturers (2014-2019)
- 3.2.2 Transdermal Drug Delivery System Revenue Share by Manufacturers (2014-2019)
- 3.3 Transdermal Drug Delivery System Price by Manufacturers
- 3.4 Transdermal Drug Delivery System Manufacturing Base Distribution, Product Types
- 3.4.1 Transdermal Drug Delivery System Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Transdermal Drug Delivery System Product Type
- 3.4.3 Date of International Manufacturers Enter into Transdermal Drug Delivery System Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Transdermal Drug Delivery System Sales by Product
- 4.2 Global Transdermal Drug Delivery System Revenue by Product
- 4.3 Transdermal Drug Delivery System Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Transdermal Drug Delivery System Breakdown Data by End User
6 North America
- 6.1 North America Transdermal Drug Delivery System by Countries
- 6.1.1 North America Transdermal Drug Delivery System Sales by Countries
- 6.1.2 North America Transdermal Drug Delivery System Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Transdermal Drug Delivery System by Product
- 6.3 North America Transdermal Drug Delivery System by End User
7 Europe
- 7.1 Europe Transdermal Drug Delivery System by Countries
- 7.1.1 Europe Transdermal Drug Delivery System Sales by Countries
- 7.1.2 Europe Transdermal Drug Delivery System Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Transdermal Drug Delivery System by Product
- 7.3 Europe Transdermal Drug Delivery System by End User
8 Asia Pacific
- 8.1 Asia Pacific Transdermal Drug Delivery System by Countries
- 8.1.1 Asia Pacific Transdermal Drug Delivery System Sales by Countries
- 8.1.2 Asia Pacific Transdermal Drug Delivery System Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Transdermal Drug Delivery System by Product
- 8.3 Asia Pacific Transdermal Drug Delivery System by End User
9 Central & South America
- 9.1 Central & South America Transdermal Drug Delivery System by Countries
- 9.1.1 Central & South America Transdermal Drug Delivery System Sales by Countries
- 9.1.2 Central & South America Transdermal Drug Delivery System Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Transdermal Drug Delivery System by Product
- 9.3 Central & South America Transdermal Drug Delivery System by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Transdermal Drug Delivery System by Countries
- 10.1.1 Middle East and Africa Transdermal Drug Delivery System Sales by Countries
- 10.1.2 Middle East and Africa Transdermal Drug Delivery System Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Transdermal Drug Delivery System by Product
- 10.3 Middle East and Africa Transdermal Drug Delivery System by End User
11 Company Profiles
- 11.1 Novartis AG
- 11.1.1 Novartis AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis AG Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis AG Transdermal Drug Delivery System Products Offered
- 11.1.5 Novartis AG Recent Development
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Johnson & Johnson Transdermal Drug Delivery System Products Offered
- 11.2.5 Johnson & Johnson Recent Development
- 11.3 Mylan Pharmaceuticals, Inc
- 11.3.1 Mylan Pharmaceuticals, Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Products Offered
- 11.3.5 Mylan Pharmaceuticals, Inc Recent Development
- 11.4 Boehringer Ingelheim GmbH
- 11.4.1 Boehringer Ingelheim GmbH Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Boehringer Ingelheim GmbH Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Boehringer Ingelheim GmbH Transdermal Drug Delivery System Products Offered
- 11.4.5 Boehringer Ingelheim GmbH Recent Development
- 11.5 Biogel Technology, Inc.
- 11.5.1 Biogel Technology, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Biogel Technology, Inc. Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Biogel Technology, Inc. Transdermal Drug Delivery System Products Offered
- 11.5.5 Biogel Technology, Inc. Recent Development
- 11.6 Transdermal Technologies, Inc.
- 11.6.1 Transdermal Technologies, Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Transdermal Technologies, Inc. Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Transdermal Technologies, Inc. Transdermal Drug Delivery System Products Offered
- 11.6.5 Transdermal Technologies, Inc. Recent Development
- 11.7 Skyepharma PLC
- 11.7.1 Skyepharma PLC Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Skyepharma PLC Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Skyepharma PLC Transdermal Drug Delivery System Products Offered
- 11.7.5 Skyepharma PLC Recent Development
- 11.8 Watson Pharmaceuticals, Inc
- 11.8.1 Watson Pharmaceuticals, Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Products Offered
- 11.8.5 Watson Pharmaceuticals, Inc Recent Development
- 11.9 3M Company
- 11.9.1 3M Company Company Details
- 11.9.2 Company Business Overview
- 11.9.3 3M Company Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 3M Company Transdermal Drug Delivery System Products Offered
- 11.9.5 3M Company Recent Development
- 11.10 Noven Pharmaceuticals, Inc
- 11.10.1 Noven Pharmaceuticals, Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Products Offered
- 11.10.5 Noven Pharmaceuticals, Inc Recent Development
- 11.11 4P Therapeutics, LLC
- 11.12 Echo Therapeutics, Inc
- 11.13 Transdermal Corp
12 Future Forecast
- 12.1 Transdermal Drug Delivery System Market Forecast by Regions
- 12.1.1 Global Transdermal Drug Delivery System Sales Forecast by Regions 2019-2025
- 12.1.2 Global Transdermal Drug Delivery System Revenue Forecast by Regions 2019-2025
- 12.2 Transdermal Drug Delivery System Market Forecast by Product
- 12.2.1 Global Transdermal Drug Delivery System Sales Forecast by Product 2019-2025
- 12.2.2 Global Transdermal Drug Delivery System Revenue Forecast by Product 2019-2025
- 12.3 Transdermal Drug Delivery System Market Forecast by End User
- 12.4 North America Transdermal Drug Delivery System Forecast
- 12.5 Europe Transdermal Drug Delivery System Forecast
- 12.6 Asia Pacific Transdermal Drug Delivery System Forecast
- 12.7 Central & South America Transdermal Drug Delivery System Forecast
- 12.8 Middle East and Africa Transdermal Drug Delivery System Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Transdermal Drug Delivery System Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Transdermal Drug Delivery System . Industry analysis & Market Report on Transdermal Drug Delivery System is a syndicated market report, published as Global Transdermal Drug Delivery System Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Transdermal Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
